Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
Seung Seok Han, Do Hyoung Kim, Su Mi Lee, Na Young Han, Jung Mi Oh, Jongwon Ha, Yon Su Kim
Kidney Res Clin Pract. 2012;31(3):157-162.   Published online 2012 Jun 26     DOI: https://doi.org/10.1016/j.krcp.2012.06.007
Citations to this article as recorded by Crossref logo
Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas
Dorottya Moldvai, Dániel Sztankovics, Titanilla Dankó, Enikő Vetlényi, Gábor Petővári, Ágnes Márk, Attila Patonai, Gyula Végső, László Piros, Ádám Hosszú, Judit Pápay, Ildikó Krencz, Anna Sebestyén
British Journal of Cancer.2024; 130(7): 1119.     CrossRef
A pharmacist-led intervention to improve kidney transplant recipient outcomes and identify patients at risk of highly variable trough tacrolimus levels: a cohort study
Roxane Lhermitte, Brendan Le Daré, Florian Laval, Florian Lemaitre, Barbara Troussier, Marie-Pascale Morin, Cécile Vigneau, Jonathan M Chemouny, Astrid Bacle
European Journal of Hospital Pharmacy.2023; : ejhpharm-2022-003625.     CrossRef
Retrospective evaluation of LCP‐tacrolimus (Envarsus XR) dosing in de novo kidney transplant
Mohammed Alzahrani, Rachel M. Belcher, Jamie Benken, Benito Valdepenas, Pierpaolo Di Cocco, Mathula Kajavathanan, Scott T. Benken
Clinical Transplantation.2023;[Epub]     CrossRef
CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach
Zeyar Mohammed Ali, Marinda Meertens, Beatriz Fernández, Pere Fontova, Anna Vidal-Alabró, Raul Rigo-Bonnin, Edoardo Melilli, Josep M. Cruzado, Josep M. Grinyó, Helena Colom, Nuria Lloberas
Pharmaceutics.2023; 15(12): 2699.     CrossRef
Pharmacokinetics of tacrolimus following an overdose in a patient with extreme obesity and genotype CYP3A5*3/*3: a case report
Toshinori Hirai, Yoshihiko Morikawa, Noriko Sasaki, Hideo Kato, Daisuke Nakato, Masahiro Hirayama, Tadashi Kaneko, Hiroshi Imai, Takuya Iwamoto
The Journal of Toxicological Sciences.2022; 47(2): 71.     CrossRef
Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
M. I. Francke, W. J. Visser, D. Severs, A. M. E. de Mik - van Egmond, D. A. Hesselink, B. C. M. De Winter
European Journal of Clinical Pharmacology.2022; 78(8): 1273.     CrossRef
Implications for body weight extremes in solid organ transplantation
Maya Campara, Laura M. Lourenco, Jennifer I. Melaragno, Tiffany E. Kaiser
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2021; 41(1): 44.     CrossRef
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis
Carlos Rafael-Vidal, Irene Altabás, Nair Pérez, Coral Mourino Rodríguez, Jose M. Pego-Reigosa, Samuel Garcia
International Journal of Molecular Sciences.2021; 22(3): 1263.     CrossRef
Tacrolimus Exposure in Obese Patients: and A Case–Control Study in Kidney Transplantation
Vincent Robert, Emmanuelle Manos-Sampol, Thibaut Manson, Thomas Robert, Nicolas Decourchelle, Anne-Sophie Gruliere, Sylvie Quaranta, Valérie Moal, Tristan Legris
Therapeutic Drug Monitoring.2021; 43(2): 229.     CrossRef
The Relationship between Initial Tacrolimus Metabolism Rate and Recipients Body Composition in Kidney Transplantation
Aureliusz Kolonko, Patrycja Pokora, Natalia Słabiak-Błaż, Beata Czerwieńska, Henryk Karkoszka, Piotr Kuczera, Grzegorz Piecha, Andrzej Więcek
Journal of Clinical Medicine.2021; 10(24): 5793.     CrossRef
Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients
Eleonore Fröhlich
Current Drug Metabolism.2020; 20(13): 1039.     CrossRef
Dosing algorithm for Tacrolimus in Tunisian Kidney transplant patients: Effect of CYP 3A4*1B and CYP3A4*22 polymorphisms
Nadia Ben-Fredj, Ibtissem Hannachi, Zohra Chadli, Haifa Ben-Romdhane, Naceur A Boughattas, Najah Ben-Fadhel, Karim Aouam
Toxicology and Applied Pharmacology.2020; 407: 115245.     CrossRef
Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients
Lu Chen, Xiaoqing Lu, Guijun Tan, Liqin Zhu, Yihe Liu, Mengxue Li
Xenobiotica.2020; 50(2): 196.     CrossRef
Weight‐based tacrolimus trough concentrations post liver transplant
Zheng Liu, Jeffrey Cheng, Elizabeth Powell, Graeme Macdonald, Jonathan Fawcett, Stephen Lynch, Jennifer Martin
Internal Medicine Journal.2019; 49(1): 79.     CrossRef
Personalized immunosuppression in elderly renal transplant recipients
L.E.J. Peeters, L.M. Andrews, D.A. Hesselink, B.C.M. de Winter, T. van Gelder
Pharmacological Research.2018; 130: 303.     CrossRef
Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
Kinga Krzyżowska, Aureliusz Kolonko, Piotr Giza, Jerzy Chudek, Andrzej Więcek
BioMed Research International.2018; 2018: 1.     CrossRef
Understanding alterations in drug handling with aging
Steven Gabardi, Stefan G. Tullius, Felix Krenzien
Current Opinion in Organ Transplantation.2015; 20(4): 424.     CrossRef